Breast cancer confounding factors epidemiology. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Lymph Nodes Neoplastic Stem Cells Neoplastic Cells, Circulating Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases45

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Genetic Predisposition to Disease Carcinoma, Intraductal, Noninfiltrating Carcinoma Neoplasms, Hormone-Dependent Lymphatic Metastasis Mammary Neoplasms, Experimental Ovarian Neoplasms Neoplasm Recurrence, Local Neoplasms Lung Neoplasms Fibrocystic Breast Disease Disease Progression Prostatic Neoplasms Bone Neoplasms Colonic Neoplasms Carcinoma, Ductal Carcinoma in Situ Neoplasms, Second Primary Stomach Neoplasms Cell Transformation, Neoplastic Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Adenocarcinoma Pancreatic Neoplasms Fibroadenoma Uterine Cervical Neoplasms Cardiac Complexes, Premature Neoplastic Cells, Circulating Neovascularization, Pathologic Neoplasms, Radiation-Induced Colorectal Neoplasms Neoplasms, Basal Cell Endometrial Neoplasms Carcinoma, Squamous Cell Mammary Neoplasms, Animal Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Lymphedema

Chemicals and Drugs53

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Estrogen Receptor alpha Estrogens BRCA2 Protein BRCA1 Protein Aromatase Inhibitors RNA, Messenger Estrogen Antagonists DNA, Neoplasm Estradiol Fluorouracil RNA, Small Interfering Antibodies, Monoclonal, Humanized Cyclophosphamide Estrogen Receptor Modulators Epirubicin Selective Estrogen Receptor Modulators Cyclopenthiazide Tumor Suppressor Protein p53 Nitriles Antibodies, Monoclonal Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Paclitaxel Ki-67 Antigen RNA, Neoplasm Cancer Vaccines Antigens, Neoplasm Anticarcinogenic Agents Antigens, CD24 Triazoles Mucin-1 Transcription Factors Anthracyclines MicroRNAs Antibiotics, Antineoplastic DNA-Binding Proteins Complement Factor D Proto-Oncogene Proteins c-akt DNA Primers Cyclin D1 Doxorubicin Progestins Proto-Oncogene Proteins Nuclear Proteins Methotrexate

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Molecular Epidemiology Mammography Prognosis Risk Factors Neoplasm Staging Early Detection of Cancer Mastectomy Incidence Chemotherapy, Adjuvant Case-Control Studies Survival Analysis Risk Antineoplastic Combined Chemotherapy Protocols SEER Program Follow-Up Studies Retrospective Studies Breast Self-Examination Disease-Free Survival Survival Rate Prospective Studies Mammary Neoplasms, Experimental Risk Assessment Gene Expression Profiling Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Odds Ratio Cohort Studies Treatment Outcome Mastectomy, Segmental Registries Multivariate Analysis Xenograft Model Antitumor Assays Blotting, Western Logistic Models Questionnaires Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis Ultrasonography, Mammary Neoplasm Transplantation Transplantation, Heterologous Kaplan-Meier Estimate Predictive Value of Tests Reproducibility of Results Mass Screening Tissue Array Analysis Combined Modality Therapy Tumor Burden Breast Implants Confidence Intervals Radiotherapy, Adjuvant Prevalence Neoplasm Grading Mammaplasty Transfection Clinical Trials as Topic Immunoenzyme Techniques Proportional Hazards Models Neoadjuvant Therapy Genetic Testing Cluster Analysis Radiotherapy Drug Screening Assays, Antitumor Biopsy, Needle Estrogen Replacement Therapy Drug Administration Schedule Sentinel Lymph Node Biopsy Lymph Node Excision Biopsy Gene Knockdown Techniques Models, Biological In Situ Hybridization, Fluorescence DNA Mutational Analysis Mastectomy, Radical Population Surveillance Epidemiologic Methods Reproductive History

Psychiatry and Psychology4

Breast Feeding Breast Self-Examination Parapsychology Smoking

Phenomena and Processes48

Gene Expression Regulation, Neoplastic Genes, BRCA1 Postmenopause Genetic Predisposition to Disease Breast Feeding Risk Premenopause Drug Resistance, Neoplasm Cell Proliferation Menopause Odds Ratio Genes, BRCA2 Genotype Genes, erbB-2 Time Factors Mutation Apoptosis Signal Transduction Cell Movement Cell Division Polymorphism, Genetic Germ-Line Mutation Down-Regulation DNA Methylation Promoter Regions, Genetic Cell Growth Processes Gene Amplification Transfection Parity Dose-Response Relationship, Drug Cell Cycle RNA Interference Up-Regulation Phenotype Base Sequence Gene Silencing Cell Survival Gene Expression Diet Genes, Tumor Suppressor Alleles Genes, Neoplasm Phosphorylation Epithelial-Mesenchymal Transition Genes, p53 Polymorphism, Single Nucleotide Heterozygote Drug Synergism

Disciplines and Occupations5

Epidemiology Molecular Epidemiology Immunohistochemistry Parapsychology Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Age Distribution Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science8

Incidence SEER Program Survival Rate Registries Questionnaires Prevalence Molecular Sequence Data Base Sequence

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care41

Molecular Epidemiology Risk Factors Incidence Case-Control Studies Survival Analysis Risk Age Factors SEER Program Follow-Up Studies Retrospective Studies Disease-Free Survival Survival Rate Prospective Studies Risk Assessment Odds Ratio Cohort Studies Treatment Outcome Registries Multivariate Analysis Logistic Models Questionnaires Kaplan-Meier Estimate Predictive Value of Tests Reproducibility of Results Mass Screening Age Distribution Confidence Intervals Prevalence Clinical Trials as Topic Confounding Factors (Epidemiology)Parity Proportional Hazards Models Genetic Testing Cluster Analysis National Cancer Institute (U.S.)Age of Onset Family Health Population Surveillance Epidemiologic Methods Reproductive History Bias (Epidemiology)

Geographicals6

United States China Sweden Japan Europe California

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Breast Neoplasms Carcinoma, Ductal, Breast Epidemiology Receptors, Estrogen Cell Line, Tumor Breast Diseases Receptor, erbB-2 Tamoxifen Molecular Epidemiology Receptors, Progesterone Mammography Gene Expression Regulation, Neoplastic Prognosis Neoplasm Metastasis Neoplasm Invasiveness Risk Factors Tumor Markers, Biological Breast Neoplasms, Male Antineoplastic Agents, Hormonal Neoplasm Staging Early Detection of Cancer Mastectomy Incidence Genes, BRCA1 Antineoplastic Agents Neoplasm Proteins Postmenopause Chemotherapy, Adjuvant Carcinoma, Lobular Genetic Predisposition to Disease Case-Control Studies Carcinoma, Intraductal, Noninfiltrating Survival Analysis MCF-7 Cells Breast Feeding Mice, Nude Risk Age Factors Premenopause Antineoplastic Combined Chemotherapy Protocols Tumor Cells, Cultured Estrogen Receptor alpha Drug Resistance, Neoplasm Estrogens Carcinoma SEER Program Follow-Up Studies United States Retrospective Studies Breast Self-Examination Disease-Free Survival Neoplasms, Hormone-Dependent Survival Rate Prospective Studies Lymphatic Metastasis Mammary Neoplasms, Experimental Ovarian Neoplasms Risk Assessment Gene Expression Profiling Immunohistochemistry Cell Proliferation Neoplasm Recurrence, Local Menopause Reverse Transcriptase Polymerase Chain Reaction BRCA2 Protein Neoplasms Odds Ratio Genes, BRCA2 BRCA1 Protein Lung Neoplasms Survivors Cohort Studies Fibrocystic Breast Disease Aromatase Inhibitors RNA, Messenger Disease Progression Estrogen Antagonists Treatment Outcome Mastectomy, Segmental Genotype Registries Axilla Genes, erbB-2 Prostatic Neoplasms Time Factors Mammary Glands, Human Multivariate Analysis DNA, Neoplasm Mutation Xenograft Model Antitumor Assays Blotting, Western Parapsychology Estradiol Apoptosis Signal Transduction Fluorouracil Bone Neoplasms RNA, Small Interfering Logistic Models

No FAQ available that match "breast cancer confounding factors epidemiology"